Decheng Capital China Life Sciences Usd Fund Iii, L.P. Alpine Immune Sciences, Inc. (ALPN) insider trading activity

Decheng Capital China Life Sciences Usd Fund Iii, L.P. is > 10% Shareholder of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 6.58 Million shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on Jan 18, 2024, when has been sold 1,234,636 shares (Common Stock) at a price of $12.74 per share, resulting in proceeds of $15,729,262. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.58M

0% 3M change

23.09% 12M change

Total Value Held $0

Decheng Capital China Life Sciences USD Fund III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 18 2024	BUY Exercise of in-the-money or at-the-money derivatives securities	$15,729,262 $12.74 p/Share	1,234,636 Added 15.79%	6,582,380 Common Stock
Sep 23 2022	BUY Grant, award, or other acquisition	$4,700,002 $7.35 p/Share	639,456 Added 10.68%	5,347,744 Common Stock
Sep 17 2021	BUY Open market or private purchase	$14,499,998 $9.4 p/Share	1,542,553 Added 24.68%	4,708,288 Common Stock

Also insider at

HLTH

Cue Health Inc. Healthcare

DCC